SAN DIEGO, Nov. 2, 2015 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing therapies for the treatment of central nervous system (CNS) disorders, today announced that it will report its financial results for the third quarter ended September 30, 2015 after the market close, and will host a corporate update conference call and webcast on Monday, November 9, 2015, at 4:30pm Eastern Time.
| Monday, November 9th @ 4:30pm Eastern Time/1:30pm Pacific Time | |
| Toll Free: | 888-523-1228 |
| International: | 719-325-2308 |
| Conference ID: | 660434 |
| Webcast: | http://public.viavid.com/player/index.php?id=116611 |
| Replays, available through November 23, 2015: | |
| Domestic: | 877-870-5176 |
| International: | 858-384-5517 |
| Conference ID: | 660434 |
About Zogenix
Zogenix, Inc. (Nasdaq:ZGNX) is a pharmaceutical company committed to developing and commercializing CNS therapies that address specific clinical needs for people living with orphan and other CNS disorders who need innovative treatment alternatives to help them return to normal daily functioning.
For more information, visit www.zogenix.com.
CONTACT: Investors: Andrew McDonald Founding Partner, LifeSci Advisors LLC 646-597-6987 | Andrew@lifesciadvisors.com
Help employers find you! Check out all the jobs and post your resume.
